Search for: "GlaxoSmithKline and SmithKline Beecham Corporation"
Results 1 - 20
of 20
Sorted by Relevance
|
Sort by Date
8 Oct 2009, 1:56 pm
PRESS RELEASE: GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO’s motion to dismiss its litigation over Final Regulations published in August 2007 (Triantafyllos Tafas and SmithKline Beecham Corporation, SmithKline Beecham PLC and Glaxo Group Limited vs. [read post]
6 Apr 2012, 10:36 am
Smithkline Beecham Corp., 2012 WL 1057435 (E.D. [read post]
3 Jul 2012, 6:13 am
SmithKline Beecham Corp., dba GlaxoSmithKline, No. 11-204. [read post]
22 Jan 2008, 4:30 am
SmithKline Beecham Corporation d/b/a GlaxoSmithKline, Civil No. 07-3483 (D. [read post]
11 Oct 2007, 2:32 pm
According to the fifty-two page, eight-count complaint signed by Sherry Knowles, Global Head of Corporate Intellectual Property for SmithKline Beecham,3. [read post]
13 Nov 2009, 11:52 am
USPTO Agrees to Withdraw Claims & Continuations Rules PRESS RELEASE: GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO's motion to dismiss its litigation over Final Regulations published in August 2007 (Triantafyllos Tafas and SmithKline Beecham Corporation, SmithKline Beecham PLC and Glaxo Group Limited vs. [read post]
12 Oct 2007, 6:42 am
This time, the plaintiff is pharmaceutical giant SmithKline Beecham Corporation (d/b/a GlaxoSmithKline). [read post]
3 Jun 2013, 8:38 am
An antitrust class action lawsuit against Valeant Pharmaceuticals Inc. and SmithKline Beecham Corp., doing business as GlaxoSmithKline and GlaxoSmithKline plc (jointly “GSK”) claimed that these corporations, the ones responsible for the production and marketing of Wellbutrin XL, worked to limit the availability of generic versions of Wellbutrin XL, far less expensive alternatives to the brand-name medication. [read post]
9 Oct 2009, 11:50 am
In his remarks before thousands of employees on the USPTO campus, Secretary Locke said "David is taking on a big job… Promoting and protecting U.S. [...]...USPTO Agrees to Withdraw Claims & Continuations Rules PRESS RELEASE: GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO’s motion to dismiss its litigation over Final Regulations published in August 2007… [read post]
19 Oct 2009, 5:53 pm
It is impossible not to recognize the new [...]...USPTO Agrees to Withdraw Claims & Continuations Rules PRESS RELEASE: GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO’s motion to dismiss its litigation over Final Regulations published in August 2007 (Triantafyllos Tafas and SmithKline Beecham Corporation, SmithKline… [read post]
10 May 2010, 5:33 am
GlaxoSmithKline removed the case to SD Illinois federal court and plaintiffs sought remand. [read post]
1 May 2017, 8:00 am
SmithKline Beecham Corporation d/b/a GlaxoSmithKline, No. 12-CV-06403 (U.S. [read post]
6 Apr 2010, 4:01 am
Smithkline Beecham Corporation, dba Glaxosmithkline, No. 09-10806 (11th Cir. [read post]
14 May 2008, 5:20 am
Antitrust Class Action by Assignees of Direct Purchasers of Antidepressant Wellbutrin SR Satisfied Rule 23 Class Action Requirements Pennsylvania Federal Court Holds Plaintiffs filed a class action complaint against SmithKline Beecham Corporation dba GlaxoSmithKline (GSK) alleging antitrust violations arising out of its manufacture and sale of the antidepressant drug Wellbutrin SR. [read post]
31 Oct 2007, 12:25 pm
In a lawsuit against the USPTO, SmithKline Beecham Corporation (d/b/a GlaxoSmithKline) filed suit in the United Stated Federal District Court asking the court to preliminarily and permanently enjoin the PTO from implementing the Final Rules contending that the Final Rules are vague, arbitrary and capricious, and prevent GSK (not to mention everyone else) from fully prosecuting patent applications and obtaining patents on one or more of its inventions. [read post]
11 Jun 2013, 10:50 am
SmithKline Beecham Corporation, Slip Op.(3d Cir. [read post]
18 Jun 2012, 1:38 pm
SmithKline Beecham Corporation involved the case of two pharmaceutical sales representatives for GlaxoSmithKline who filed suit for overtime compensation they had not been paid under the Federal Labor Standards Act. [read post]
7 Nov 2007, 6:29 pm
SmithKline Beecham Corporation (doing business as GlaxoSmithKline (“GSK”)), stepped up and sued the PTO, seeking both a preliminary injunction and a permanent injunction to prevent the new rules from going into effect. [read post]
2 Feb 2011, 4:28 pm
SMITHKLINE BEECHAM CORPORATION, d.b.a. [read post]
1 Apr 2008, 8:27 am
He was joined by SmithKline Beecham Corporation (d/b/a GlaxoSmithKline). [read post]
